EMAIL THIS PAGE TO A FRIEND

PloS one

Protective Macroautophagy Is Involved in Vitamin E Succinate Effects on Human Gastric Carcinoma Cell Line SGC-7901 by Inhibiting mTOR Axis Phosphorylation.


PMID 26168048

Abstract

Vitamin E succinate (VES), a potential cancer therapeutic agent, potently induces apoptosis and inhibits the growth of various cancer cells. Autophagy has been supposed to promote cancer cell survival or trigger cell death, depending on particular cancer types and tumor microenvironments. The role of autophagy in the growth suppressive effect of VES on gastric cancer cell is basically unknown. We aimed to determine whether and how autophagy affected the VES-induced inhibition of SGC-7901 human gastric carcinoma cell growth. SGC-7901 cells were treated with VES or pre-treated with autophagy inhibitor, chloroquine (CQ) and 3-methyladenine (3-MA). Electron microscopy, fluorescence microscopy and Western blot were used to study whether VES induced autophagy reaction in SGC-7901 cells. Western blot evaluated the activities of the mammalian target of rapamycin (mTOR) axis. Then we used 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and flow cytometry to detect the level of cell viability and apoptosis. Collectively, our data indeed strongly support our hypothesis that VES treatment produced cytological variations that depict autophagy, increased the amount of intracellular green fluorescent protein-microtubule associated protein 1 light chain 3 (GFP-LC3) punctate fluorescence and the number of autophagic vacuoles. It altered the expression of endogenous autophagy marker LC3. VES activated the suppression of mTOR through inhibiting upstream regulators p38 MAPK and Akt. mTOR suppression consequently inhibited the activation of mTOR downstream targets p70S6K and 4E-BP-1. The activation of the upstream mTOR inhibitor AMPK had been up-regulated by VES. The results showed that pre-treatment SGC-7901 with autophagy inhibitors before VES treatment could increase the capacity of VES to reduce cell viability and to provoke apoptosis. In conclusion, VES-induced autophagy participates in SGC-7901 cell protection by inhibiting mTOR axis phosphorylation. Our findings not only strengthen our understanding of the roles of autophagy in cancer biology, but may also be useful for developing new treatments for gastric cancer patients.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

AV36578
Anti-ANXA3 (AB1) antibody produced in rabbit, IgG fraction of antiserum
AV36579
Anti-ANXA3 (AB2) antibody produced in rabbit, IgG fraction of antiserum
SAB1405458
Anti-ANXA3 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
HPA013398
Anti-ANXA3 antibody produced in rabbit, Ab1, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
HPA013431
Anti-ANXA3 antibody produced in rabbit, Ab2, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB1305638 ANTI-LC3 (APG8A) antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
SAB1306269
ANTI-LC3 (APG8A/B) antibody produced in rabbit, purified immunoglobulin, buffered aqueous solution
L8918
Anti-LC3 antibody produced in rabbit, ~1 mg/mL, affinity isolated antibody, buffered aqueous solution
L8793
Anti-LC3A antibody produced in rabbit, ~1 mg/mL, affinity isolated antibody, buffered aqueous solution
SAB1408113
Anti-MAP1LC3A antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
HPA007649
Anti-MAP1LC3A antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB2101425
Anti-MAP1LC3A antibody produced in rabbit, affinity isolated antibody
SAB4300571
Anti-MAP1LC3A antibody produced in rabbit, affinity isolated antibody
SAB1411514
Anti-MAP1LC3A antibody produced in rabbit, purified immunoglobulin, buffered aqueous solution
SAB3501064
Anti-MAP1LC3A antibody produced in rabbit, affinity isolated antibody
SAB4503853
Anti-phospho-Akt (pSer124) antibody produced in rabbit, affinity isolated antibody
SAB4504016
Anti-phospho-Akt (pSer129) antibody produced in rabbit, affinity isolated antibody
SAB4504015
Anti-phospho-Akt (pSer246) antibody produced in rabbit, affinity isolated antibody
SAB4504331
Anti-phospho-Akt (pSer473) antibody produced in rabbit, affinity isolated antibody
SAB4504332
Anti-phospho-Akt (pThr308) antibody produced in rabbit, affinity isolated antibody
SAB4504017
Anti-phospho-Akt (pThr72) antibody produced in rabbit, affinity isolated antibody
SAB4504110
Anti-phospho-Akt (pTyr326) antibody produced in rabbit, affinity isolated antibody
SAB4504014
Anti-phospho-Akt (pTyr474) antibody produced in rabbit, affinity isolated antibody
SAB4300042
Anti-phospho-AKT1 (pSer473) antibody produced in rabbit, affinity isolated antibody
SAB4300043
Anti-phospho-AKT1 (pThr308) antibody produced in rabbit, affinity isolated antibody
SAB4504749
Anti-phospho-AKT1 (pThr308) antibody produced in rabbit, affinity isolated antibody
SAB4503852
Anti-phospho-Akt1 (pThr450) antibody produced in rabbit, affinity isolated antibody
SAB4300260
Anti-phospho-AKT1 (pThr450) antibody produced in rabbit, affinity isolated antibody
SAB4300200
Anti-phospho-MAPK14 (pThr180) antibody produced in rabbit, affinity isolated antibody
SAB4300201
Anti-phospho-MAPK14 (pTyr182) antibody produced in rabbit, affinity isolated antibody